off-label use of glp-1 agonists for obesity in 2016 Health Disparity Clusters Off Label Prescriptions Glucagon-Like Peptide 1 Receptor GLP-1 receptor agonists and next-generation

And if you're looking for a safe place to heal your relationship with food, body, and self you're in the right place

M.et al (2022)

This expansion of therapeutic indications has not only increased the demand for GLP-1 receptor agonists but also positioned them as versatile agents in managing complex, multifactorial health conditions

Although these drugs demonstrated effectiveness in improving blood sugar control and promoting weight loss, lawsuits now allege that GLP-1 receptor agonists may also be associated with severe gastrointestinal injuries, optic nerve complications, and other serious adverse health effects

A thorough review of the studies that led to tirzepatides approval allows for comparisons between tirzepatide and GLP-1 RAs

Its one of the two GLP-1 RAs approved for weight loss by the FDA and the only one approved for treatment of metabolic-associated fatty liver disease (MASH)